Literature DB >> 14872330

[Antidepressants and anticonvulsive agents. Practical utility profile in pain therapy].

V Lindner1, G Deuschl.   

Abstract

Antidepressants are used in the treatment of neuropathic pain syndromes, as prophylaxis for primary headache syndromes, and in the treatment of fibromyalgia. Anticonvulsants are suited for therapy of all neuropathic pain syndromes, and can be applied as the method of second choice for certain headache syndromes. All substances tested with good results are tricyclic antidepressants. Their psychotropic action profile should be taken into consideration when planning therapy. Their antidepressive effect does not coincide with the effect of pain reduction. Therapy should start with a slow increase of the dose and can be prolonged as monotherapy or in combination with other analgetics. Carbamazepine is used in the treatment of shooting neuralgic pain attacks, whereas gabapentin has become the agent of first choice in the therapy of permanent neuropathic pain. Other substances in this group should be reserved for extraordinary situations based on their license and side effect profile.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14872330     DOI: 10.1007/s00482-003-0295-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  13 in total

Review 1.  Anticonvulsants in central pain.

Authors:  Nanna B Finnerup; Hanne Gottrup; Troels S Jensen
Journal:  Expert Opin Pharmacother       Date:  2002-10       Impact factor: 3.889

Review 2.  Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.

Authors:  S L Collins; R A Moore; P Wiffen
Journal:  J Pain Symptom Manage       Date:  2000-12       Impact factor: 3.612

3.  [Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis].

Authors:  V Homberg; A Kowalik; A Schulze-Bonhage
Journal:  Nervenarzt       Date:  2001-12       Impact factor: 1.214

4.  Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

Authors:  S H Sindrup; F W Bach; C Madsen; L F Gram; T S Jensen
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

Review 5.  [Neuropathic pain. The long path from mechanisms to mechanism-based treatment].

Authors:  R Baron
Journal:  Anaesthesist       Date:  2000-05       Impact factor: 1.041

Review 6.  Use of anticonvulsants for treatment of neuropathic pain.

Authors:  Misha-Miroslav Backonja
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

7.  Lamotrigine for central poststroke pain: a randomized controlled trial.

Authors:  K Vestergaard; G Andersen; H Gottrup; B T Kristensen; T S Jensen
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

8.  [Prophylactic drug management of migraine].

Authors:  H Göbel; A Heinze
Journal:  Schmerz       Date:  2002-06       Impact factor: 1.107

9.  Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies.

Authors:  Patrick Onghena; Boudewijn Van Houdenhove
Journal:  Pain       Date:  1992-05       Impact factor: 6.961

Review 10.  [Glutamate antagonists for treatment of neuropathic pain].

Authors:  F Block; B Habermeyer
Journal:  Schmerz       Date:  2003-08       Impact factor: 1.107

View more
  2 in total

Review 1.  [Chronic pain in everyday medical routine].

Authors:  D Rothstein; M Zenz
Journal:  Internist (Berl)       Date:  2005-10       Impact factor: 0.743

2.  Guideline "diagnosis and non interventional therapy of neuropathic pain" of the German Society of Neurology (deutsche Gesellschaft für Neurologie).

Authors:  Tanja Schlereth
Journal:  Neurol Res Pract       Date:  2020-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.